Contract W911QY20C0100
Modernatx, Inc. · Department Of Defense · September 14, 2021
Modernatx, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on September 14, 2021 for $8.20 billion (current value) of work in pharmaceutical preparation manufacturing. Performance is in Cambridge, MA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 23, 2022. If all options are exercised, the contract could reach $8.20 billion.
Contract details
- PIID
- W911QY20C0100
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Cambridge, MA
- First action
- September 14, 2021
- Latest action
- September 23, 2022
Description
COVID-19 VACCINES: RESCISSION OF HRPAS/DPAS RATING
Modification timeline
-
September 23, 2022Mod P00025 · Other Administrative Action$8.20B
-
September 30, 2021Mod P00017 · Other Administrative ActionCOVID-19 VACCINES$8.20B
-
September 14, 2021Mod P00016 · Other Administrative ActionCOVID-19 VACCINE$8.20B
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W911QY20C0100?
Contract W911QY20C0100 is a federal contract awarded to Modernatx, Inc. by Department Of Defense on September 14, 2021 for $8.20 billion of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract W911QY20C0100?
Modernatx, Inc. won contract W911QY20C0100 from Department Of Defense.
How much is contract W911QY20C0100 worth?
Contract W911QY20C0100 has obligated $0 to date but carries a potential ceiling of $8.20 billion if fully funded and all options are exercised.